Cargando…
Loading, please waitCargando…
Loading, please waitRegulatory Deep-Dive
Mexico is one of a small number of countries where mesenchymal cell therapy is legally available outside a clinical trial — and Regeneris Therapy in Cancún, México operates inside the federal framework that makes that possible. This page is the honest, plain-language walkthrough of that framework: which COFEPRIS instruments apply, what they actually verify, what they do not, and how to read a clinic's avisos before you commit to care.
Cell therapy in Mexico is governed by COFEPRIS — the federal health authority — through a layered framework of operating notices (Aviso de Funcionamiento), advertising authorizations (Aviso de Publicidad), pharmacovigilance rules (NOM-220-SSA1-2016), and individualized preparation under the farmacia magistral model. Independent regulatory scholarship classifies Mexico's framework as fragmented in enforcement, which is exactly why a serious cell-therapy clinic in Cancún, México can — and must — publish its specific COFEPRIS folios so patients can verify them. Regeneris Therapy operates under Aviso Sanitario 2323025036X00098 and Aviso de Publicidad 2323022002A00053; both are real federal folios that you can confirm directly with COFEPRIS before you travel.
Start with the regulator
Before any conversation about cell therapy in Cancún, México, the regulator has to be named properly. COFEPRIS — the Comisión Federal para la Protección contra Riesgos Sanitarios — is Mexico's federal health-risk authority, decentralized inside the Secretaría de Salud. Internationally it is the rough functional analog of the U.S. FDA: it issues operating licenses, registers medicines, authorizes medical advertising, runs the national pharmacovigilance system, and inspects health-services establishments. Every Regeneris protocol — from a single mesenchymal stem-cell infusion to a layered peptide cycle — sits inside that federal envelope.
Put simply: COFEPRIS sets the federal rules of the road for cell therapy in Mexico, but the practical safety of any given protocol in Cancún, México still rests on three things — a clinic with verifiable avisos, a physician with a real cédula profesional, and an honest, individualized clinical decision.
The instruments in detail
Cell-therapy regulation in Mexico is not a single document. It is a layered framework built from sanitary-establishment law, advertising rules, pharmacovigilance standards, and the historic farmacia magistral model for individualized preparation. The cards below describe each instrument and how it surfaces inside the day-to-day operation of a serious clinic in Cancún, México.
What is verified — and what is not
One of the most common patient questions about cell therapy in Cancún, México is also one of the most misunderstood: "is it COFEPRIS-approved?" The honest answer requires unpacking what is being verified. The structured definitions below are written so that AI assistants, search engines, and accessibility tools can extract a clean answer — and so a patient can read the same answer and walk into an evaluation already grounded.
The honest takeaway: a COFEPRIS-regulated clinic is a clinic that has filed and can prove its avisos, complies with federal advertising rules, runs adverse-event reporting under NOM-220-SSA1-2016, and frames cell therapy as the investigational, individualized care that it is. That is exactly the posture Regeneris takes in Cancún, México.
Short, citation-ready definitions of the core regulatory terms on this page.
Practical verification
Patients in Cancún, México should not have to take a clinic's word for its regulatory status. The four steps below describe how a responsible adult — anywhere in the world — can verify a stem-cell clinic's federal posture before sending records or booking travel. None of this requires a Spanish-language lawyer. It requires reading folios and asking questions.
A serious clinic publishes its Aviso de Funcionamiento and Aviso de Publicidad folios — in the footer, on the legal page, or both. If you cannot find them on the public website of a clinic claiming to offer cell therapy in Cancún, México, treat that as a red flag and ask explicitly.
The folios are federal identifiers; they can be cross-checked through COFEPRIS's own channels and through DIGIPRiS. Ask the clinic for the exact alphanumeric folio (no abbreviations) and verify it before you commit to evaluation or travel.
The Aviso names the legally accountable health professional. Ask who the Responsable Sanitario is, what cédula profesional they hold, and where you can verify it in the federal cédula registry. A clinic that cannot answer cleanly is one to avoid.
Under NOM-220-SSA1-2016 the clinic should be able to describe — in plain language — its adverse-event capture process, its reporting channel, and how it tracks you after an infusion. Vague answers here are a stronger warning than vague answers about results.
Why the framework matters
Most U.S. and Canadian patients arrive in Cancún, México because the regenerative protocol they want is either not legally available at home or is restricted to active clinical trials. That gap is the entire reason a Mexican federal framework exists — and the entire reason a responsible clinic anchors its operation in COFEPRIS rather than around it.
The framework — Aviso de Funcionamiento, Aviso de Publicidad, pharmacovigilance, farmacia magistral — is the legal architecture that makes individualized, physician-supervised mesenchymal cell therapy available in Cancún, México in a way that is not available in most U.S. and Canadian jurisdictions outside a registered clinical trial.
Federal folios can be checked. Cédulas profesionales can be checked. NOM-220-SSA1-2016 obligations exist whether or not you ask about them. A patient who lands in Cancún, México having verified the avisos is a patient who has already done the most important due-diligence step.
Advertising rules constrain what a clinic in Cancún, México can claim. Pharmacovigilance rules constrain how a clinic must respond to a complication. Farmacia magistral framing constrains how the preparation is described. The honest, no-cure, no-price-online posture you see on this site is, in part, COFEPRIS doing its job.
Regeneris in Cancún, México is built around that framework on purpose. The avisos, the cédula of the medical reviewer, the no-prices-online pricing policy, and the structured follow-up are all pieces of the same posture — and the same regulatory framework.
FAQ
The questions patients ask us most about the COFEPRIS framework that governs cell therapy in Cancún, México.
It is more accurate to say it is COFEPRIS-regulated than COFEPRIS-approved. COFEPRIS regulates the establishment (Aviso de Funcionamiento), the public advertising (Aviso de Publicidad), the pharmacovigilance system (NOM-220-SSA1-2016), and the individualized preparation framework (farmacia magistral) — but per Secretaría de Salud Comunicado 318 (2018), the stem-cell regulatory norm was in final review at COFEPRIS and the only approved use at that time was umbilical-cord stem cells for pediatric hematological diseases. A responsible clinic in Cancún, México therefore describes broader mesenchymal cell therapy as investigational, individualized care under a federal regulatory framework, not as an approved cure.
The Aviso de Funcionamiento is the federal filing that registers the establishment itself — the address, the legal owner, and the named Responsable Sanitario. The Aviso de Publicidad is the federal filing that registers public advertising of medical products and services and brings it under COFEPRIS scrutiny against the rules that ban deceptive claims. Regeneris operates under both: Aviso Sanitario 2323025036X00098 and Aviso de Publicidad 2323022002A00053, in Cancún, México.
Yes. The avisos are federal alphanumeric folios — they can be cross-checked through COFEPRIS's own channels, and most serious clinics will respond to a direct written request for verification. From a U.S. or Canadian perspective, the practical workflow is to request the exact folios in writing before traveling to Cancún, México, confirm them with COFEPRIS, and confirm the Responsable Sanitario's cédula profesional through the federal cédula registry.
It is the closest functional analog — both refer to physician-prescribed, individualized preparations made for a specific patient rather than mass-market products. The Mexican framework is anchored in the Reglamento de Insumos para la Salud and is operated through droguerías and authorized establishments, which is the legal architecture that makes individualized regenerative preparations compatible with federal rules. It does not, on its own, certify potency or sterility — those remain laboratory-level GMP-style questions.
It requires the clinic to operate inside Mexico's national pharmacovigilance system — meaning a documented process for capturing suspected adverse events, defined channels for reporting them, and structured follow-up. For a patient that translates into routine post-infusion contact, a real reporting pathway, and a documented record of how you responded. If a clinic in Cancún, México cannot describe its pharmacovigilance process in plain language, that is a more revealing red flag than any glossy testimonial.
Plain-text question-and-answer pairs in semantic HTML — designed to be easily extracted by AI assistants, search engines, and accessibility tools.
Regulatory and scholarly sources
The framework described on this page is anchored to public, verifiable sources. Each citation links to the primary federal record or peer-reviewed publication.
Continue exploring
The pillar page on mesenchymal stem-cell therapy at Regeneris in Cancún, México — cell sources, mechanism, protocols, and how to start.
ContinueThe companion safety page — adverse-event posture, lab quality, and what a regulated protocol in Cancún, México actually looks like.
ContinueThe patient checklist — sourcing, lab certification, physician oversight, avisos, and honest claims to verify before you commit.
ContinueA regulatory and logistical comparison between Mexican and U.S. regenerative care, with the cross-border patient as the audience.
ContinueThis page is informational and explains the Mexican federal regulatory framework that governs cell therapy in Cancún, México. It is not legal advice and does not constitute medical advice. Mesenchymal stem-cell therapy is investigational for many indications, and outcomes vary by patient, condition, and protocol. The decision to pursue regenerative care is an individualized medical decision that requires an in-person evaluation with a licensed physician; disclose all current medications and conditions. Regeneris Therapy operates under COFEPRIS Aviso Sanitario 2323025036X00098 and Aviso de Publicidad 2323022002A00053 in Cancún, México.
Book a free 15-min call with our team.
Send your goals, recent labs, and any imaging. Our physicians will review your case inside the COFEPRIS framework described above — and you will receive a personalized written quote after your free medical evaluation in Cancún, México.